State of Alaska Department of Revenue’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $911K | Sell |
|
|||||
|
2025
Q2 | $659K | Buy |
|
|||||
|
2025
Q1 | $615K | Sell |
|
|||||
|
2024
Q4 | $520K | Sell |
|
|||||
|
2024
Q3 | $564K | Buy |
|
|||||
|
2024
Q2 | $573K | Sell |
|
|||||
|
2024
Q1 | $634K | Sell |
|
|||||
|
2023
Q4 | $547K | Sell |
|
|||||
|
2023
Q3 | $579K | Buy |
|
|||||
|
2023
Q2 | $493K | Buy |
|
|||||
|
2023
Q1 | $332K | Sell |
|
|||||
|
2022
Q4 | $342K | Buy |
|
|||||
|
2022
Q3 | $268K | Sell |
|
|||||
|
2022
Q2 | $271K | Buy |
|
|||||
|
2022
Q1 | $248K | Buy |
|
|||||
|
2021
Q4 | $353K | Buy |
|
|||||
|
2021
Q3 | $236K | Buy |
|
|||||
|
2021
Q2 | $240K | Buy |
|
|||||
|
2021
Q1 | $235K | Sell |
|
|||||
|
2020
Q4 | $217K | Sell |
|
|||||
|
2020
Q3 | $252K | Buy |
|
|||||
|
2020
Q2 | $282K | Buy |
|
|||||
|
2020
Q1 | $351K | Buy |
|
|||||
|
2019
Q4 | $433K | Sell |
|
|||||
|
2019
Q3 | $520K | Buy |
|
|||||
|
2019
Q2 | $235K | Buy |
|
|||||
|
2019
Q1 | $197K | Buy |
|
|||||
|
2018
Q4 | $124K | Sell |
|
|||||
|
2018
Q3 | $167K | Hold |
|
|||||
|
2018
Q2 | $198K | Buy |
|
|||||
|
2018
Q1 | $167K | Buy |
|
|||||
|
2017
Q4 | $114K | Hold |
|
|||||
|
2017
Q3 | $93K | Buy |
|
|||||
|
2017
Q2 | $74K | Buy |
|
|||||
|
2017
Q1 | $43K | Buy |
|
|||||
|
2016
Q4 | $52K | Buy |
|